Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad Zamani
Rohit Loomba

Showing results (1-10 of 744) with videos related to

Pageof 75
Sort By:
Alimentary Pharmacology & Therapeutics|March 11, 2022
Meta-analysis: prevalence of, and risk factors for, non-alcoholic fatty liver disease in patients with inflammatory bowel diseaseMohammad Zamani, Shaghayegh Alizadeh-Tabari, Siddharth Singh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 5, 2023
Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-analysisMohammad Zamani, Shaghayegh Alizadeh-Tabari, Puja Chitkara, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 29, 2024
Global Prevalence of Advanced Liver Fibrosis and Cirrhosis in the General Population: A Systematic Review and Meta-analysisMohammad Zamani, Shaghayegh Alizadeh-Tabari, Veeral Ajmera, et al.
Journal of Hepatology|December 6, 2017
Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directionsRohit Loomba
Cureus|January 1, 2016
Thrombocytosis in the Setting of Isomerism and a Functionally Univentricular HeartRohit Loomba
Seminars in Liver Disease|February 23, 2018
Can Elastography Differentiate Isolated Fatty Liver from Nonalcoholic Steatohepatitis?Veeral Ajmera, Rohit Loomba
Current Treatment Options in Gastroenterology|March 15, 2021
An update on the role of the microbiome in non-alcoholic fatty liver disease pathogenesis, diagnosis, and treatmentMarialena Mouzaki, Rohit Loomba
Journal of Clinical Gastroenterology|December 3, 2019
The Role of Noninvasive Tests for Differentiating NASH From NAFL and Diagnosing Advanced Fibrosis Among Patients With NAFLDMaya Balakrishnan, Rohit Loomba
Journal of Clinical and Experimental Hepatology|January 24, 2022
Magnetic Resonance Elastography for the Clinical Risk Assessment of Fibrosis, Cirrhosis, and Portal Hypertension in Patients With NAFLDYamini Natarajan, Rohit Loomba
Therapeutic Advances in Gastroenterology|July 2, 2019
Insights into the evolving role of the gut microbiome in nonalcoholic fatty liver disease: rationale and prospects for therapeutic interventionMarialena Mouzaki, Rohit Loomba
Pageof 75

Showing results (1-10 of 744) with videos related to

Sort By:
Pageof 75
Alimentary Pharmacology & Therapeutics|March 11, 2022
Meta-analysis: prevalence of, and risk factors for, non-alcoholic fatty liver disease in patients with inflammatory bowel diseaseMohammad Zamani, Shaghayegh Alizadeh-Tabari, Siddharth Singh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 5, 2023
Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-analysisMohammad Zamani, Shaghayegh Alizadeh-Tabari, Puja Chitkara, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 29, 2024
Global Prevalence of Advanced Liver Fibrosis and Cirrhosis in the General Population: A Systematic Review and Meta-analysisMohammad Zamani, Shaghayegh Alizadeh-Tabari, Veeral Ajmera, et al.
Journal of Hepatology|December 6, 2017
Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directionsRohit Loomba
Cureus|January 1, 2016
Thrombocytosis in the Setting of Isomerism and a Functionally Univentricular HeartRohit Loomba
Seminars in Liver Disease|February 23, 2018
Can Elastography Differentiate Isolated Fatty Liver from Nonalcoholic Steatohepatitis?Veeral Ajmera, Rohit Loomba
Current Treatment Options in Gastroenterology|March 15, 2021
An update on the role of the microbiome in non-alcoholic fatty liver disease pathogenesis, diagnosis, and treatmentMarialena Mouzaki, Rohit Loomba
Journal of Clinical Gastroenterology|December 3, 2019
The Role of Noninvasive Tests for Differentiating NASH From NAFL and Diagnosing Advanced Fibrosis Among Patients With NAFLDMaya Balakrishnan, Rohit Loomba
Journal of Clinical and Experimental Hepatology|January 24, 2022
Magnetic Resonance Elastography for the Clinical Risk Assessment of Fibrosis, Cirrhosis, and Portal Hypertension in Patients With NAFLDYamini Natarajan, Rohit Loomba
Therapeutic Advances in Gastroenterology|July 2, 2019
Insights into the evolving role of the gut microbiome in nonalcoholic fatty liver disease: rationale and prospects for therapeutic interventionMarialena Mouzaki, Rohit Loomba
Pageof 75